ClariVest Asset Management LLC - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$457
-12.8%
26,702
-0.4%
0.02%
-20.0%
Q4 2022$524
-99.9%
26,800
-0.7%
0.02%
+19.0%
Q3 2022$431,000
+14266.7%
27,000
+13962.5%
0.02%
Q1 2020$3,000
-25.0%
1920.0%0.00%
Q4 2019$4,0001920.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders